{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:05:24Z","timestamp":1774883124800,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"DOI":"10.7759\/cureus.106129","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:31:21Z","timestamp":1774881081000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Prospective Audit and Feedback Antimicrobial Stewardship Strategy: A Retrospective Analysis in a Tertiary Hospital in Colombia"],"prefix":"10.7759","author":[{"given":"Santiago","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna","family":"Mora-Robayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paula","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00862-6","article-title":"Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis","volume":"2024","author":"Lewnard JA","unstructured":"Lewnard JA, Charani E, Gleason A, et al.. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. Lancet Lond Engl. 1, 2024:2439-54. 10.1016\/S0140-6736(24)00862-6","journal-title":"Lancet Lond Engl"},{"key":"ref2","unstructured":"Confronting antimicrobial resistance 2024 to 2029. (2024). Accessed. June15, 2025: https:\/\/www.gov.uk\/government\/publications\/uk-5-year-action-plan-for-antimicrobial-resistance-2024-to-2029\/confrontin...."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam TF","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al.. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016, 62:e51-77. 10.1093\/cid\/ciw118","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab430","article-title":"Development of the three antimicrobial stewardship E's (TASE) framework and association between stewardship interventions and intended results analysis to identify key facility-specific interventions and strategies for successful antimicrobial stewardship","volume":"73","author":"Kimball JM","year":"2021","unstructured":"Kimball JM, Deri CR, Nesbitt WJ, Nelson GE, Staub MB. Development of the three antimicrobial stewardship E's (TASE) framework and association between stewardship interventions and intended results analysis to identify key facility-specific interventions and strategies for successful antimicrobial stewardship. Clin Infect Dis. 2021, 73:1397-403. 10.1093\/cid\/ciab430","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.11683","article-title":"Prescribing trends before and after implementation of an antimicrobial stewardship program","volume":"198","author":"Cairns KA","year":"2013","unstructured":"Cairns KA, Jenney AW, Abbott IJ, Skinner MJ, Doyle JS, Dooley M, Cheng AC. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust. 2013, 198:262-6. 10.5694\/mja12.11683","journal-title":"Med J Aust"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182017000300001","article-title":"Impact of rational use of antibiotics in a third level clinic in Colombia (Article in Spanish)","volume":"34","author":"Pallares CJ","year":"2017","unstructured":"Pallares CJ, Cata\u00f1o JC. Impact of rational use of antibiotics in a third level clinic in Colombia (Article in Spanish). Rev Chilena Infectol. 2017, 34:205-11. 10.4067\/S0716-10182017000300001","journal-title":"Rev Chilena Infectol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.130042","article-title":"Switch over from intravenous to oral therapy: a concise overview","volume":"5","author":"Cyriac JM","year":"2014","unstructured":"Cyriac JM, James E. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother. 2014, 5:83-7. 10.4103\/0976-500X.130042","journal-title":"J Pharmacol Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2024.02.005","article-title":"Managing antimicrobial resistance in the emergency department","volume":"42","author":"Yeary J","year":"2024","unstructured":"Yeary J, Hacker L, Liang SY. Managing antimicrobial resistance in the emergency department. Emerg Med Clin North Am. 2024, 42:461-83. 10.1016\/j.emc.2024.02.005","journal-title":"Emerg Med Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2020.03.010","article-title":"Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: a real-world analysis 2010-2018","volume":"26","author":"Kimura T","year":"2020","unstructured":"Kimura T, Ito M, Onozawa S. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: a real-world analysis 2010-2018. J Infect Chemother. 2020, 26:706-14. 10.1016\/j.jiac.2020.03.010","journal-title":"J Infect Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2020.008","article-title":"Oral or intravenous antibiotics?","volume":"43","author":"McCarthy K","year":"2020","unstructured":"McCarthy K, Avent M. Oral or intravenous antibiotics?. Aust Prescr. 2020, 43:45-8. 10.18773\/austprescr.2020.008","journal-title":"Aust Prescr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.05.012","article-title":"Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections","volume":"26","author":"Al-Hasan MN","year":"2020","unstructured":"Al-Hasan MN, Rac H. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections. Clin Microbiol Infect. 2020, 26:299-306. 10.1016\/j.cmi.2019.05.012","journal-title":"Clin Microbiol Infect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac197","article-title":"Early switch from intravenous to oral antibiotics in skin and soft tissue infections: an algorithm-based prospective multicenter pilot trial","volume":"9","author":"Dellsperger S","year":"2022","unstructured":"Dellsperger S, Kramer S, Stoller M, et al.. Early switch from intravenous to oral antibiotics in skin and soft tissue infections: an algorithm-based prospective multicenter pilot trial. Open Forum Infect Dis. 2022, 9:ofac197. 10.1093\/ofid\/ofac197","journal-title":"Open Forum Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.04.030","article-title":"Choosing patients over placebos: oral transitional therapy vs. IV-only therapy for bacteraemia and infective endocarditis","volume":"29","author":"Phillips MC","year":"2023","unstructured":"Phillips MC, Wald-Dickler N, Davar K, Lee R, Baden R, Holtom P, Spellberg B. Choosing patients over placebos: oral transitional therapy vs. IV-only therapy for bacteraemia and infective endocarditis. Clin Microbiol Infect. 2023, 29:1126-32. 10.1016\/j.cmi.2023.04.030","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.04.026","article-title":"Early switch to oral antimicrobials in brain abscess: a narrative review","volume":"29","author":"Bodilsen J","year":"2023","unstructured":"Bodilsen J, Nielsen H. Early switch to oral antimicrobials in brain abscess: a narrative review. Clin Microbiol Infect. 2023, 29:1139-43. 10.1016\/j.cmi.2023.04.026","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.52314","article-title":"Early switch from intravenous to oral antibiotics for patients with uncomplicated Gram-negative bacteremia","volume":"7","author":"Tingsg\u00e5rd S","year":"2024","unstructured":"Tingsg\u00e5rd S, Bastrup Israelsen S, J\u00f8rgensen HL, \u00d8stergaard C, Benfield T. Early switch from intravenous to oral antibiotics for patients with uncomplicated Gram-negative bacteremia. JAMA Netw Open. 2024, 7:e2352314. 10.1001\/jamanetworkopen.2023.52314","journal-title":"JAMA Netw Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59026-2","article-title":"Oral versus intravenous antibiotic treatment of moderate-to-severe community-acquired pneumonia: a propensity score matched study","volume":"14","author":"Kaal AG","year":"2024","unstructured":"Kaal AG, Roos R, de Jong P, et al.. Oral versus intravenous antibiotic treatment of moderate-to-severe community-acquired pneumonia: a propensity score matched study. Sci Rep. 2024, 14:8271. 10.1038\/s41598-024-59026-2","journal-title":"Sci Rep"},{"key":"ref17","unstructured":"The R Project for Statistical Computing. (2025). https.\/\/www.r-project.org\/."},{"key":"ref18","unstructured":"How to make antimicrobial stewardship work. practical considerations for hospitals of all sizes. (2017). Accessed: July 8, 2025: https:\/\/journals.sagepub.com\/doi\/10.1310\/hpj4511-s10."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw210","article-title":"How to pitch an antibiotic stewardship program to the hospital C-suite","volume":"3","author":"Spellberg B","year":"2016","unstructured":"Spellberg B, Bartlett JG, Gilbert DN. How to pitch an antibiotic stewardship program to the hospital C-suite. Open Forum Infect Dis. 2016, 3:ofw210. 10.1093\/ofid\/ofw210","journal-title":"Open Forum Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003543.pub4","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"2","author":"Davey P","year":"2017","unstructured":"Davey P, Marwick CA, Scott CL, et al.. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017, 2:CD003543. 10.1002\/14651858.CD003543.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1561275","article-title":"Efficacy and safety of antimicrobial de-escalation as a clinical strategy","volume":"17","author":"Mathieu C","year":"2019","unstructured":"Mathieu C, Pastene B, Cassir N, Martin-Loeches I, Leone M. Efficacy and safety of antimicrobial de-escalation as a clinical strategy. Expert Rev Anti Infect Ther. 2019, 17:79-88. 10.1080\/14787210.2019.1561275","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05866-w","article-title":"Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)","volume":"46","author":"Tabah A","year":"2020","unstructured":"Tabah A, Bassetti M, Kollef MH, et al.. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med. 2020, 46:245-65. 10.1007\/s00134-019-05866-w","journal-title":"Intensive Care Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2020.52.1.19","article-title":"Antimicrobial therapy and antimicrobial stewardship in sepsis","volume":"52","author":"Seok H","year":"2020","unstructured":"Seok H, Jeon JH, Park DW. Antimicrobial therapy and antimicrobial stewardship in sepsis. Infect Chemother. 2020, 52:19-30. 10.3947\/ic.2020.52.1.19","journal-title":"Infect Chemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2011.0358","article-title":"Antimicrobial stewardship","volume":"86","author":"Doron S","year":"2011","unstructured":"Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc. 2011, 86:1113-23. 10.4065\/mcp.2011.0358","journal-title":"Mayo Clin Proc"},{"key":"ref25","article-title":"Stewardship in sepsis","volume":"2","author":"Del Pozo JL","year":"2019","unstructured":"Del Pozo JL. Stewardship in sepsis. Rev Esp Quimioter. 2019, 2:42-6.","journal-title":"Rev Esp Quimioter"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1134","article-title":"Short-course antibiotic therapy-replacing constantine units with \"shorter is better\"","volume":"69","author":"Wald-Dickler N","year":"2019","unstructured":"Wald-Dickler N, Spellberg B. Short-course antibiotic therapy-replacing constantine units with \"shorter is better\". Clin Infect Dis. 2019, 69:1476-9. 10.1093\/cid\/ciy1134","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000680","article-title":"Antibiotic treatment of common infections: more evidence to support shorter durations","volume":"33","author":"Smith BJ","year":"2020","unstructured":"Smith BJ, Heriot G, Buising K. Antibiotic treatment of common infections: more evidence to support shorter durations. Curr Opin Infect Dis. 2020, 33:433-40. 10.1097\/QCO.0000000000000680","journal-title":"Curr Opin Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000689","article-title":"Duration of antimicrobial therapy for Gram-negative infections","volume":"33","author":"Le Fevre L","year":"2020","unstructured":"Le Fevre L, Timsit JF. Duration of antimicrobial therapy for Gram-negative infections. Curr Opin Infect Dis. 2020, 33:511-6. 10.1097\/QCO.0000000000000689","journal-title":"Curr Opin Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf344","article-title":"Target trial emulation of empiric antibiotics on clinical outcomes in moderately immunocompromised patients hospitalized with pneumonia","author":"Saravolatz L","year":"2025","unstructured":"Saravolatz L, Gandhi TN, Vaughn VM, et al.. Target trial emulation of empiric antibiotics on clinical outcomes in moderately immunocompromised patients hospitalized with pneumonia. Clin Infect Dis. 2025, ciaf344. 10.1093\/cid\/ciaf344","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use","volume":"3","author":"Rhee C","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP, et al.. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020, 3:e202899. 10.1001\/jamanetworkopen.2020.2899","journal-title":"JAMA Netw Open"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2011.09.018","article-title":"Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document (Article in Spanish)","volume":"30","author":"Rodr\u00edguez-Ba\u00f1o J","year":"2012","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Pa\u00f1o-Pardo JR, Alvarez-Rocha L, et al.. Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document (Article in Spanish). Enferm Infecc Microbiol Clin. 2012, 30:22.e1-23. 10.1016\/j.eimc.2011.09.018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref32","article-title":"Antimicrobial stewardship programme implementation in a medical ward (Article in Spanish)","volume":"31","author":"Ruiz J","year":"2018","unstructured":"Ruiz J, Salavert M, Ram\u00edrez P, et al.. Antimicrobial stewardship programme implementation in a medical ward (Article in Spanish). Rev Esp Quimioter. 2018, 31:419-26.","journal-title":"Rev Esp Quimioter"},{"key":"ref33","article-title":"Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations","volume":"79","author":"Duane TM","year":"2013","unstructured":"Duane TM, Zuo JX, Wolfe LG, et al.. Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg. 2013, 79:1269-72.","journal-title":"Am Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53806","article-title":"Association between antimicrobial stewardship programs and antibiotic use globally: a systematic review and meta-analysis","volume":"6","author":"Zay Ya K","year":"2023","unstructured":"Zay Ya K, Win PT, Bielicki J, Lambiris M, Fink G. Association between antimicrobial stewardship programs and antibiotic use globally: a systematic review and meta-analysis. JAMA Netw Open. 2023, 6:e2253806. 10.1001\/jamanetworkopen.2022.53806","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471926-impact-of-prospective-audit-and-feedback-antimicrobial-stewardship-strategy-a-retrospective-analysis-in-a-tertiary-hospital-in-colombia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:31:24Z","timestamp":1774881084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471926-impact-of-prospective-audit-and-feedback-antimicrobial-stewardship-strategy-a-retrospective-analysis-in-a-tertiary-hospital-in-colombia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.106129","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}